AMIT KUMAR - 15 Sep 2022 Form 4 Insider Report for Anixa Biosciences Inc (ANIX)

Role
Chief Executive Officer, Director
Signature
/s/ Amit Kumar
Issuer symbol
ANIX
Transactions as of
15 Sep 2022
Transactions value $
-$555,712
Form type
4
Filing time
16 Sep 2022, 17:20:18 UTC
Previous filing
11 Mar 2022
Next filing
04 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANIX Common Stock Options Exercise $1.65M +640K +203.82% $2.58 954K 15 Sep 2022 Direct
transaction ANIX Common Stock Tax liability -$2.2M -492K -51.56% $4.48 462K 15 Sep 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ANIX Employee Stock Option (Right to Buy) Options Exercise $0 -640K -100% $0.00* 0 15 Sep 2022 Common Stock 640K $2.58 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting persons exercised the stock options at this time due to their expiration on September 19, 2022. The disposal of shares reported herein represents shares withheld by Anixa Biosciences, Inc. (the "registrant") to (i) cover the exercise price of the stock options and (ii) satisfy tax withholding obligations in connection with the exercise of the stock options. Dr. Kumar did not sell any shares in connection with the exercise of the options.
F2 Right-To-Buy, pursuant to a stock option grant dated September 19, 2012.